ERBB2 and cancer: Data on variables such as age, parity, menopause, cancer stage and grade, estrogen receptor (ER), progesterone receptor (PR), HER2/neu, Ki67 score, and the use of biologicals, hormones, and chemoradiotherapy were analyzed using correlation and regression tests to identify factors associated with aggressive tumor behavior.